GridAI Technologies (GRDX) Total Liabilities (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Total Liabilities came in at $18.3 million in Q2 2026, down 38.44% on a YoY basis from $29.7 million in Q2 2025, and down 7.36% quarter-over-quarter from $19.7 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Total Liabilities (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Total Liabilities for 12 consecutive years, with $18.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Liabilities fell 38.44% year-over-year to $18.3 million; the trailing twelve-month figure through Jun 2026 stood at $18.3 million (down 38.44% YoY), and the FY2025 full-year result was $19.7 million, down 28.57% from the prior year.
- Total Liabilities slipped to $18.3 million in Q2 2026 per GRDX's latest filing, from $19.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $45.8 million in Q3 2025 and bottomed at $2.6 million in Q3 2023.
- Historically, Total Liabilities has averaged $16.0 million across 5 years, with a median of $15.8 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities sank 86.25% in 2022, then surged 741.55% in 2024.
- Over 5 years, Total Liabilities stood at $2.7 million in 2022, then grew by 21.6% to $3.3 million in 2023, then soared by 741.55% to $27.6 million in 2024, then declined by 28.57% to $19.7 million in 2025, then declined by 7.36% to $18.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $18.3 million, $19.7 million, and $45.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.62 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 4.20 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 384.62 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 18.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.27 Mn |
| Dec 31, 2025 | 19.72 Mn |
| Sep 30, 2025 | 45.81 Mn |
| Jun 30, 2025 | 29.68 Mn |
| Mar 31, 2025 | 28.74 Mn |
| Dec 31, 2024 | 27.61 Mn |
| Sep 30, 2024 | 15.77 Mn |
| Jun 30, 2024 | 15.49 Mn |
| Mar 31, 2024 | 13.27 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 18.12 Mn |
| Mar 31, 2022 | 18.07 Mn |
| Dec 31, 2021 | 19.61 Mn |
| Sep 30, 2021 | 19.39 Mn |
| Jun 30, 2021 | 6.74 Mn |